Flavin Ventures

Flavin Ventures provides entrepreneurial expertise to life science companies expecting to cross the divide between proprietary research activities and commercial success. We also leverage the significant relationships that the managing directors have established with other venture capital groups, primarily located on the East and West coasts of the United States, into co-investment or follow-on investment activity in Flavin Ventures' portfolio companies. We have significant experience in the management of commercial R&D programs, product development, commercialization and alliances, capital raising, legal and governmental affairs and company management including start-up, M&A and IPO projects. One of Flavin Ventures’ most valuable assets is its management expertise in overcoming the scientific and financial obstacles that start-up life science companies inevitably encounter on their path toward success.

David Eiznhamer Ph.D

Principal

1 past transactions

Molecular Formulations

Seed Round in 2004
Molecular Formulations, LLC is a life sciences R&D company that offers a broad range of services in pharmaceutical sciences to pharmaceutical and biotechnology clients. We provide high value R&D services spanning from physicochemical characterization through prototype formulation and stability study evaluation. Our drug development services and technologies are focused on determining the drug-like character of the molecule and then developing a prototype formulation suitable for toxicology and dose ranging studies. Molecular Formulations, LLC is the newest addition to the Flavin Ventures, LLC portfolio of biotechnology companies. Flavin Ventures, LLC is an early stage venture capital and management group for innovative Midwestern life sciences companies focused on drug discovery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.